The DOI matches its Crossref record; 112 of the 115 references it cites were found in a registry or an index.
A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins
Open accessAbstract
One-fourth of all deaths in industrialized countries result from coronary heart disease. A century of research has revealed the essential causative agent: cholesterol-carrying low-density lipoprotein (LDL). LDL is controlled by specific receptors (LDLRs) in liver that remove it from blood. Mutations that eliminate LDLRs raise LDL and cause heart attacks in childhood, whereas mutations that raise LDLRs reduce LDL and diminish heart attacks. If we are to eliminate coronary disease, lowering LDL should be the primary goal. Effective means to achieve this goal are currently available. The key questions are: who to treat, when to treat, and how long to treat.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The receptors for LDL (LDLR) and transferrin receptor (TFR) are both endocytosed from the cell surface via clathrin-coated vesicles and transported through intracellular recycling pathways (14, 15, 16, 17, 18, 19, 20).”
From The small GTPase RAB10 regulates endosomal recycling of the LDL receptor and transferrin receptor in hepatocytes (2022) · cites this paper as [14]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“LDLR plays a crucial role in the uptake of LDL-C from the circulation by hepatocytes 1,2,7 .”
From Dietary cholesterol activates a Ral-dependent pathway driving LDLR turnover (2026) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“The regulation of LDLR trafficking and turnover is essential for maintaining cholesterol homeostasis and remains a major focus of therapeutic strategies for CVD 1,2,7 .”
From Dietary cholesterol activates a Ral-dependent pathway driving LDLR turnover (2026) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“Elevated LDL-C levels are linked to an increased risk of ASCVD,4,5”
From Sirtuin-1 directly binds and deacetylates hepatic PCSK9 thereby promoting the inhibition of LDL receptor degradation (2025) · cites this paper as [5]
In the citing paper
“Unlike common diseases, the clarity of causation for Mendelian disorders usually simplifies the task of generating models (including human cells and organoids or rodents) to connect genotype to organismal phenotype; these have led to many critical insights into the biology of health and disease in humans98,99.”
From A brief history of human disease genetics (2020) · cites this paper as [98]
In the citing paper
“These data suggest that lifelong lower levels of plasma LDL cholesterol are much more effective than late LDL reductions induced by statins in preventing coronary heart disease (31).”
From Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms (2018) · cites this paper as [31]
In the citing paper
“Hypercholesterolemia is one of the key risk factors in promoting atherosclerosis, which is the underlying cause of approximately 90% of cases of myocardial infarction, 60% of strokes, most cases of chronic heart failure, peripheral arterial disease, and vascular dementia (31).”
From Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms (2018) · cites this paper as [31]
In the citing paper
“An example is the J-shaped association between alcohol consumption and cardiovascular disease; there is now consensus that this apparent protective effect of moderate levels of consumption is artefactual, as discussed above.130”
From Mendelian randomization (2022) · cites this paper as [130]
In the citing paper
“For example, a large-effect genetic variant influencing alcohol consumption that has been of considerable value in MR studies of the effects of alcohol75,130 is only prevalent in East Asian populations.”
From Mendelian randomization (2022) · cites this paper as [130]
In the citing paper
“Mutations in LDLR cause familial hypercholesterolemia (FH), characterized by elevated levels of plasma LDL-C and increased risk of coronary heart disease (1).”
From Identification of amino acid residues in the MT-loop of MT1-MMP critical for its ability to cleave low-density lipoprotein receptor (2022) · cites this paper as [1]
In the citing paper
“Statins block cholesterol synthesis by suppressing HMG-CoA reductase91”
From EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitis (2025) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Self-citation(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
Self-citationSREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Self-citationProgress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
Self-citation
Flagged first, then by citations
3 of the 115 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Anitschkow, 1913, Ueber experimentelle cholesterinsteatose und ihre bedeutung für die entstehung einiger pathologischer prozesse, Zentralbl. Allg. Pathol. Anat., 24, 1
- Goldstein, 1982, Lipoprotein receptors: Genetic defense against atherosclerosis, Clin. Res., 30, 417
Cited by
Sorted by citations
Items 701–800 of 1,000
The Impact of the Apolipoprotein E Genotype on Cardiovascular Disease and Cognitive Disorders
McMaster, M. W., Shah, A., Kangarlu, J., Cheikhali, R., Frishman, W. H., & Aronow, W. S. (2024) · Cardiology in Review · doi:10.1097/crd.0000000000000703 · Cited by 9
Gao, W., Guo, X., Sun, L., Gai, J., Cao, Y., & Zhang, S. (2024) · PeerJ · doi:10.7717/peerj.17749 · Cited by 6
Roles of ABCA1 in Chronic Obstructive Pulmonary Disease
Gu, Y., Bi, X., Liu, X., Qian, Q., Wen, Y., Hua, S., Fu, Q., Zheng, Y., & Sun, S. (2025) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2025.2493701 · Cited by 8
Shi, S., Liu, Y., Li, X., Zhao, W. H., Feng, H., He, J., Guo, J., Hung, W., Wang, F., Zhang, L., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144420 · Cited by 6
Sphingosine-1-phosphate signalling activates E-Syt1 to facilitate HDL-derived cholesterol transport
Xu, Z., Meng, Y., St‐Germain, J. R., Afshari, A., Dixon, C. L., Heybrock, S., Zhao, Q., Weng, X., Chen, J., Collins, R. F., et al. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01665-2 · Cited by 9
Zaher, N. H., Rashed, E. R., & El‐Ghazaly, M. A. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0054 · Cited by 6
Managing the Burden of Dementia-Related Delusions and Hallucinations
Small (2020) · The Journal of Family Practice · doi:10.12788/jfp.0065 · Cited by 6
Tan, X., Liu, S., Yao, L., Cui, G., Liu, J., & Ding, J. (2022) · Journal of Oncology · doi:10.1155/2022/8028825 · Cited by 6
Activation of circulating monocytes by low-density lipoprotein—a risk factor for osteoarthritis?
Kruisbergen, N. N. L., van Gemert, Y., Blom, A. B., van den Bosch, M. H. J., & van Lent, P. L. E. M. (2022) · Lara D. Veeken · doi:10.1093/rheumatology/keac359 · Cited by 6
Statin-induced increase in actin polymerization modulates GPCR dynamics and compartmentalization
Sarkar, P., & Chattopadhyay, A. (2022) · Biophysical Journal · doi:10.1016/j.bpj.2022.08.039 · Cited by 6
Glucagon and Thyroid Hormone: A Championship Team
Saghatelian, A., & Cravatt, B. F. (2016) · Cell · doi:10.1016/j.cell.2016.10.008 · Cited by 6
Drouin‐Chartier, J., Hogue, J., Tremblay, A. J., Bergeron, J., Lamarche, B., & Couture, P. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0502-x · Cited by 6
Herencia, J. A. C., Rueda, M. S., Bru, A. P., Escribano, F. M., García, I. P., Ródenas, L. M. A., Bernardo, D. C., Divisón, J. A., & Gil-Guillén, V. F. (2018) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2017.10.003 · Cited by 8
Management of Dyslipidemia in Type 2 Diabetes: Recent Advances in Nonstatin Treatment
Sugiyama, K., & Saisho, Y. (2018) · Diseases · doi:10.3390/diseases6020044 · Cited by 6
Plasma Lipids, Apolipoproteins, and Subsequent Cognitive Decline in Men with Coronary Heart Disease
Lutski, M., Weinstein, G., Goldbourt, U., & Tanné, D. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180849 · Cited by 6
Oxysterols and phytosterols in human health
Massaad, C., Iuliano, L., & Lizard, G. (2017) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2017.08.003 · Cited by 6
Maidman, S. D., & Rosenson, R. S. (2025) · BioDrugs · doi:10.1007/s40259-025-00731-3 · Cited by 7
Tang, H., Zhang, X., Hu, S., Song, Y., Jin, W., Zou, J., Zhang, Y., Guo, J., An, P., Luo, J., et al. (2025) · Targets · doi:10.3390/targets3030023 · Cited by 10
Wen, G., Helmerich, D. A., Behringer‐Pließ, L., & Sauer, M. (2025) · Aggregate · doi:10.1002/agt2.70104 · Cited by 5
Biochanin A as a potential agent in the disease therapy via mitochondria-mediated mechanisms
Miao, M.-A., Wu, X.-Q., Yuan, Y., Wang, Y., & Dai, W.-T. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118363 · Cited by 7
Lin, C., Wen, H., Yu, M., Huang, Q., Wang, Q., Lin, J., Yang, W., Wong, J. M. J., Xia, M., Tang, H., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04329-y · Cited by 5
Wei, J., Wang, H., Feng, T., Liu, X., Liu, Z., Li, Z., Wang, W., & Zhang, J. (2025) · Foods · doi:10.3390/foods14193452 · Cited by 5
Lipid-Related Polygenic Risk Score and Its Association With Plaque Rupture Versus Erosion
Hamana, T., Gaynor, B. J., Grogan, A., Turoni-Glitz, A., Kawakami, R., Shiraki, T., Sekimoto, T., Tanaka, T., Fujiyoshi, K., Nakayama, T., et al. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.323942 · Cited by 5
Yu, Y., Ma, Z., Li, T., Xiao, W., & Li, Z. (2026) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70248 · Cited by 5
Kawamura, K., YOSHIOKA, H., Sato, C., Yajima, T., Furuyama, Y., Kuramochi, K., & Ohgane, K. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.117145 · Cited by 5
Lin, R., Huang, Z., Liu, Y., & Zhou, Y. (2025) · Biosensors · doi:10.3390/bios15030191 · Cited by 5
Qi, H., Ogura, M., Matsuda, K., & Miida, T. (2025) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.65669 · Cited by 5
Cholesterol and Radiosensitivity
Rahal, O. M., & Woodward, W. A. (2016) · Current Breast Cancer Reports · doi:10.1007/s12609-016-0202-y · Cited by 5
Luo, Q., Chen, J., Su, Y., Wu, P., Wang, J., Fang, Z., & Luo, F. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01910-3 · Cited by 5
Wang, Z., Wang, Z., Lin, M., Zheng, B., & Zhang, J. (2023) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2023.115933 · Cited by 5
Gylling, H. K., Öörni, K., Nylund, L., Wester, I., & Simonen, P. P. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.01.022 · Cited by 5
Application of Photodynamic Therapy in Cardiology
Wańczura, P. M., Aebisher, D., Kłosowicz, M., Myśliwiec, A., Dynarowicz, K., & Bartusik‐Aebisher, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063206 · Cited by 6
Wang, X., Zhou, C., Li, Y., Yang, H., Sun, X., Li, S., & Li, J. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02802-1 · Cited by 5
Lee, M.-F., Wang, N. M., Chu, Y.-W., Wu, C., & Lin, W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011278 · Cited by 5
The pleiotropic effects of PCSK9 in cardiovascular diseases beyond cholesterol metabolism
Liu, G., Yu, X., Cui, C., Li, X., Wang, T., Palade, P., Mehta, J. L., & Wang, X. (2025) · Acta Physiologica · doi:10.1111/apha.14272 · Cited by 6
Lu, X., Ma, H., Liu, Y., Chen, M., Dang, J., Su, X., Zhao, Y., Wang, K., Yang, G., Zhang, G., et al. (2025) · Veterinary Sciences · doi:10.3390/vetsci12040314 · Cited by 5
Statins and prognosis of female breast cancer: a meta-analysis
de Moraes, F. C. A., Wagner, P. H. D. S., de Lara, I. C. A., Silva, B. L., Silva, A. L. S., Lôbo, A. D. O. M., de Carvalho, L. I. A., Kreuz, M., Magalhães, M. C. F., & Burbano, R. M. R. (2025) · Clinical & Translational Oncology · doi:10.1007/s12094-025-03935-9 · Cited by 5
Cholesterol level regulates lectin-like oxidized low-density lipoprotein receptor-1 function
Raniolo, S., Vindigni, G., & Biocca, S. (2016) · Biomedical Spectroscopy and Imaging · doi:10.3233/bsi-160156 · Cited by 5
Estridge, T. B., Dey, A., Reidy, C. A., Yu, X., Zhang, Y., Hartley, M., Milligan, P. L., Jin, N., Kowala, M. C., Leohr, J. K., et al. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.240242 · Cited by 5
Conociendo los mecanismos básicos del metabolismo de los lípidos
Álvarez‐López, H., Ruiz-Gastélum, E., & Díaz-Aragón, A. (2021) · Cardiovascular and Metabolic Science · doi:10.35366/100786 · Cited by 5
Major Concepts in Treatment with Bempedoic Acid and Inclisiran that Clinicians Need To Know
Parham, J. S., & Goldberg, A. C. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01036-4 · Cited by 5
Selective delivery of pentamidine toward cancer cells by self-assembled nanoparticles
Andreana, I., Gazzano, E., Gianquinto, E., Piatti, G., Bincoletto, V., Kryza, D., Lollo, G., Spyrakis, F., Riganti, C., Arpicco, S., et al. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122102 · Cited by 5
Алексеевна, М. О., Kholmatova, K., Постоева, А. В., Николаевна, К. Г., Malyutina, S. K., & Kudryavtsev, A. V. (2023) · Biomolecules · doi:10.3390/biom13050835 · Cited by 5
Cholesterol Lowering in Cancer Prevention and Therapy
Huang, C., & Freter, C. E. (2016) · InTech eBooks · doi:10.5772/65025 · Cited by 4
Rebaudioside A Enhances LDL Cholesterol Uptake in HepG2 Cells via Suppression of HMGCR Expression
Ilias, N., Ismail, I. S., Hamzah, H. B., Mohidin, T. B. M., Idris, M. F., Pusat Bahasa dan Pengajian Umum, U. P. S. I., & Ajat, M. (2021) · Reports of Biochemistry and Molecular Biology · doi:10.52547/rbmb.10.3.477 · Cited by 5
Inflammatory Diseases and Risk of Atherosclerotic Cardiovascular Disease: A New Focus on Prevention
Quispe, R., Varghese, B. T., & Michos, E. D. (2022) · Contemporary cardiology · doi:10.1007/978-3-030-98824-1_13 · Cited by 5
Dadson, P., Ngum, P., Juárez‐Orozco, L. E., Ntodie, M., & Loba, P. (2024) · Ophthalmology and Therapy · doi:10.1007/s40123-024-01079-7 · Cited by 4
Wu, X., Zhu, X., Fang, M., Qi, F., Yin, Z., Zhang, J. Z. H., Luo, S., Zhu, T., & Gao, Y. (2025) · Molecules · doi:10.3390/molecules30142962 · Cited by 4
Ma, W.-Q., Yang, L., Jing, Y., Ren, P., Liu, X., Zhang, M., Qi, X., Zhu, M., & Zhang, Q. (2025) · Animal Bioscience · doi:10.5713/ab.25.0405 · Cited by 4
Efficacy and Safety of HSK31679 in Asian Patients With MASLD: A Randomized Controlled Trial
Xue, F., Ma, W., Gao, J., Chen, J., Yue, W., Bu, P., Chen, Q., Chen, H., Sheng, J., Liang, C., et al. (2025) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2025.08.009 · Cited by 4
Huang, H., Wang, Y., Chen, F., Zhao, A., He, W., & Li, M. (2025) · Functional & Integrative Genomics · doi:10.1007/s10142-025-01694-y · Cited by 4
The role and mechanism of abnormal lipid metabolism in colorectal cancer
Zha, J., Cang, P., Zhong, Y., Liu, R., & Fan, G. (2025) · Science Progress · doi:10.1177/00368504251368237 · Cited by 4
Dysregulated Lipid Metabolism as a Central Driver of Atherosclerotic Plaque Pathology
Steinbeck, J. E., Iannotti, R. A., & Rasheed, A. (2025) · Lipidology · doi:10.3390/lipidology2040017 · Cited by 5
Muñoz-Zamorano, C., Yap, F. K. P., Li, L.-J., Kemp, M. W., Illanes, S. E., & Leiva, A. (2026) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2026.104540 · Cited by 5
Efficacy and Safety of Statins in MASLD and Other Chronic Liver Diseases
Commins, I., Clayton‐Chubb, D., Janko, N., Majeed, A., Kemp, W. W., & Roberts, S. K. (2026) · Medical Sciences · doi:10.3390/medsci14010084 · Cited by 4
Jiang, Y., Yu, W., Zhou, J., & Dong, X. S. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1302282 · Cited by 4
Yang, J., Zhou, J., Liu, H., Hao, J., Hu, S., Zhang, P., Wu, H., Gao, Y., & Tang, W. (2024) · Scientific Reports · doi:10.1038/s41598-024-62695-8 · Cited by 4
Wierzbicki, A. S. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2444986 · Cited by 8
Liu, X., Yin, L., Wang, F., Ao, Y., Zhuang, P., Zhang, Y., & Jiao, J. (2025) · Food & Function · doi:10.1039/d4fo05107f · Cited by 4
Wargny, M., Goronflot, T., Piriou, P., Pouriel, M., Bastien, A., Prax, J., Leux, C., Riche, V.-P., Trochu, J., Béliard, S., et al. (2025) · Diabetes & Metabolism · doi:10.1016/j.diabet.2025.101638 · Cited by 4
Redefining Macrophage Heterogeneity in Atherosclerosis: A Focus on Possible Therapeutic Implications
Kanuri, B., Maremanda, K. P., Chattopadhyay, D., Essop, M. F., Lee, M. K. S., Murphy, A. J., & Nagareddy, P. R. (2025) · Comprehensive physiology · doi:10.1002/cph4.70008 · Cited by 6
Role of Genetics in Early-Onset Cardiovascular Disease
van de Meer, M. G., van de Meer, M. G., Mumtaz, M. A., & Jawed, U. (2025) · Cureus · doi:10.7759/cureus.85988 · Cited by 4
Adropin expression reflects circadian, lipoprotein, and mitochondrial processes in human tissues
Stevens, J. R., Clemence, G., Zhou, M., Gamie, F., Aggarwal, G., McMillan, R. P., Hulver, M. W., Martinez, L. O., van der Brug, M., Vellas, B. J., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102196 · Cited by 8
Cholesterol oxidase treatment impairs CXCR4-mediated T cell migration
Gardeta, S. R., García‐Cuesta, E. M., Palacios, B. S., Ayala-Bueno, R., Quijada‐Freire, A., Acerete, N. S., Rodrı́guez-Frade, J. M., & Mellado, M. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02392-9 · Cited by 5
Martín-Campos, J. M. (2021) · Biomedicines · doi:10.3390/biomedicines9111728 · Cited by 4
Yang, L., Li, X., Wang, L., Xu, S., Lou, Y., & Hu, F. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.06.012 · Cited by 4
Yuan, H., & Xue, Y. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/2566407 · Cited by 4
Lai, X., Cui, Z., Zhang, H., Zhang, Y.-M., Wang, F., Wang, X., Meng, L.-Q., Cheng, X.-Y., Liu, G., & Zhao, M.-H. (2023) · International Urology and Nephrology · doi:10.1007/s11255-023-03467-7 · Cited by 3
Wolfkiel, P. R., Haller, A. M., Kirby, J., Jaeschke, A., & Hui, D. Y. (2023) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00007.2023 · Cited by 4
Impact of conducting a genetic study on the management of familial hypercholesterolemia
Marco-Benedí, V., Cenarro, A., Vila, À., Real, J. T., Tamarit, J. J., Álvarez-Sala, J. L., Díaz-Díaz, J. L., Perea, V., Civeira, F., & Vallejo‐Vaz, A. J. (2023) · Journal of clinical lipidology · doi:10.1016/j.jacl.2023.08.008 · Cited by 4
Shirai, K., Hitsumoto, T., Sato, S., Takahashi, M., Saiki, A., Nagayama, D., Ohira, M., Takahara, A., & Shimizu, K. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12237436 · Cited by 3
Nafsi, N. N., Rahman, M. A., Shishir, M. A., Arefin, M. S., Jime, J. S., Bulbul, N., Safa, A., & Fakruddin, M. (2024) · Current Biotechnology · doi:10.2174/0122115501282536240301055402 · Cited by 5
Bucci, T., Gue, Y. X., Dobson, R., Palmieri, C., Pignatelli, P., & Lip, G. Y. H. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01395-z · Cited by 4
Using GRAM Domain–Based Biosensors to Monitor Accessible Cholesterol Distribution in Live Cells
Naito, T., Na, M., Koh, D. H. Z., & Saheki, Y. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-4318-1_6 · Cited by 5
Evolving concepts of low‐density lipoprotein: From structure to function
Chen, C., Sawamura, T., Akhmedov, A. T., Tsai, M., Akyol, Ö., Kakino, A., Chiang, H., Kraler, S. C., & Lüscher, T. F. (2025) · European Journal of Clinical Investigation · doi:10.1111/eci.70019 · Cited by 6
Effect of 1-Kestose on Lipid Metabolism in a High-Fat-Diet Rat Model
Kuramitsu, K., Kubo, M., Cindy, F., Shibata, T., Kadota, Y., & Kitaura, Y. (2025) · Nutrients · doi:10.3390/nu17081362 · Cited by 5
A lipid in transit – the journey of cholesterol into the heart of mitochondrial research
Simmen, T., & Pellegrini, L. (2025) · Journal of Cell Science · doi:10.1242/jcs.263907 · Cited by 4
Velagapudi, S., Miranda, M. X., Adla, P., Kraler, S., Mohammed, S. A., Baki, S., Robert, J., Rohrer, L., Lee, H., Jang, H.-D., et al. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf087 · Cited by 4
Liu, M. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.05.150 · Cited by 4
Putative medicines that mimic mutations
Kathiresan, S. (2017) · Nature · doi:10.1038/nature23544 · Cited by 4
Litwack, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-383864-3.00009-0 · Cited by 4
Berton, G. S., Cordiano, R., Mahmoud, H., Palmieri, R., Cavuto, F., & Pasquinucci, M. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13492 · Cited by 4
Obesity 2021: Current Clinical Management of a Chronic, Serious Disease
Kushner (2021) · The Journal of Family Practice · doi:10.12788/jfp.0221 · Cited by 6
Analysis of the Glucose-Dependent Transcriptome in Murine Hypothalamic Cells
Webert, L., Faro, D., Zeitlmayr, S., Gudermann, T. W., & Breit, A. (2022) · Cells · doi:10.3390/cells11040639 · Cited by 4
MicroRNA-mediated reprogramming of glucose, fatty acid and amino acid metabolism in cancer
Ding, J., Wen, Y., Yuan, X., & He, X. (2022) · Genome Instability & Disease · doi:10.1007/s42764-022-00078-x · Cited by 4
Fyfe, J., Malhotra, P., & Falasca, M. (2022) · Advances in Biological Regulation · doi:10.1016/j.jbior.2022.100935 · Cited by 4
Cholesteryl hemiazelate identified in CVD patients causes in vitro and in vivo inflammation
Domingues, N. S., Gaifem, J., Matthiesen, R., Saraiva, D. P., Bento, L., Marques, A. R. A., Soares, M. I. L., Sampaio, J. L., Klose, C. D., Surma, M. A., et al. (2023) · Journal of Lipid Research · doi:10.1016/j.jlr.2023.100419 · Cited by 4
Eugeniin improves cholesterol metabolism in HepG2 cells and Caco-2 cells
Ye, Y., Takeuchi, A., Kawaguchi, Y., Matsuba, S., Zhang, N., Mijiti, M., Banno, A., Hiramatsu, N., Okada, T., & Nagaoka, S. (2023) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbad158 · Cited by 4
Highly variable biological effects of statins on cancer, non-cancer, and stem cells in vitro
Gbelcová, H., Rimpelová, S., Jariabková, A., Macášek, P., Priščáková, P., Ruml, T., Šáchová, J., Kubovčiak, J., Kolář, M., & Vítek, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-62615-w · Cited by 4
Maury, E., Brouyère, S., & Jansen, M. W. J. C. (2024) · Clinical Cardiology · doi:10.1002/clc.24330 · Cited by 4
Cholesterol in Chicken Eggs: Still a Dietary Concern for Some
Elkin, R. G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800879-9.00018-4 · Cited by 6
Pancreatic PCSK9 and its involvement in diabetes
Kockx, M., & Kritharides, L. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.06.37 · Cited by 4
Screening for Autoantibodies in Type 1 Diabetes: A Call to Action
Петерс (2021) · The Journal of Family Practice · doi:10.12788/jfp.0223 · Cited by 7
Fasano, T., Trenti, C., Negri, E. A., Guiducci, V., Foracchia, M., Bonelli, E., Canovi, S., Besutti, G., Bertolini, S., & Calandra, S. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.12.024 · Cited by 4
The Pathogenic Role of Foam Cells in Atherogenesis: Do They Represent Novel Therapeutic Targets?
Lisco, G., Giagulli, V. A., Pergola, G. D., Guastamacchia, E., Jirillo, E., & Triggiani, V. (2022) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530322666220107114313 · Cited by 4
Shi, Y., Su, Y., Liu, C., Tao, J., Fu, H., & Lu, C. (2020) · General Physiology and Biophysics · doi:10.4149/gpb_2019052 · Cited by 4
Role of Lysosomes in Lipid Metabolism
Maxfield, F. R. (2016) · Wiley eBooks · doi:10.1002/9781118978320.ch6 · Cited by 3
Linking lysosomal acid lipase insufficiency to the development of cryptogenic cirrhosis
Block, R., & Razani, B. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.04.018 · Cited by 4
Zhou, X.-W., Zhang, H., Zhang, J., Hu, T., Gong, J., Li, Y., Wang, C., Liu, J., & Wang, B. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149814 · Cited by 3
Tumor Cholesterol Synthesis, Statin Use, and Lethal Prostate Cancer
Flanagan, S., Lis, R. T., Huang, Y., Jehane, L. E., Vaselkiv, J. B., Allott, E. H., Finn, S. P., Lotan, T. L., Fiorentino, M., Loda, M. F., et al. (2025) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-24-0864 · Cited by 3
Metadata
- Authors
- Goldstein, J. L., & Brown, M. S.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Goldstein, Joseph L.
- Brown, Michael S.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 161
- Issue
- 1
- Pages
- 161-172
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC4525717
- OpenAlex
- W2160347316
- Cited by
- 1,233
- References
- 115
- Citations by year
- 2026: 101 · 2025: 134 · 2024: 117 · 2023: 121 · 2022: 136 · 2021: 150 · 2020: 116 · 2019: 105 · 2018: 87 · 2017: 84 · 2016: 61 · 2015: 19
- FWCI
- 16.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Regeneron Pharmaceuticals
- National Heart, Lung, and Blood Institute (HL-20948, P01HL020948)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- cholesterol, coronary artery disease, low-density lipoprotein, LDL receptor, LDLR mutations, familial hypercholesterolemia, statins, lipid-lowering therapy, atherosclerosis
- MeSH terms
- Animals, Cardiovascular Diseases, Cholesterol, Coronary Vessels, Dietary Fats, Humans, Receptors, LDL, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Plaque, Atherosclerotic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
